Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Aug;13(18):1633-1647.
doi: 10.2217/fon-2017-0145. Epub 2017 Aug 22.

The colorectal cancer immune microenvironment and approach to immunotherapies

Minoru Koi  1 , John M Carethers  1   2
Affiliations
Review

The colorectal cancer immune microenvironment and approach to immunotherapies

Minoru Koi et al. Future Oncol. 2017 Aug.
No abstract available

Keywords: DNA mismatch repair; EMAST; colorectal cancer; colorectal cancer molecular subtype; immune checkpoint inhibitor; immunotherapy; immunotyping; microsatellite instability; patient outcome; tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure

This work was supported by the United States Public Health Service (R01 DK067287, U01 CA162147 and R01 CA206010) and the A Alfred Taubman Medical Research Institute of the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Figures

<b>Figure 1.</b>
Figure 1.. New Immune-based therapies for primary and metastatic CRC.
(A) New adjuvant therapies for preventing/monitoring recurrence followed by resection of primary CRC. (B) New therapies for treating metastatic CRC.
See this image and copyright information in PMC

References

    1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer. 2015;136(5):E359–E386. - PubMed
    1. Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J. Clin. 2017;67(3):177–193. - PubMed
    1. Pages F, Berger A, Camus M, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N. Engl. J. Med. 2005;353(25):2654–2666. - PubMed
    1. Galon J, Costes A, Sanches-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313(5795):1960–1964. - PubMed
    1. Camus M, Tosolini M, Mlecnik B, et al. Coordination of intratumoral immune reaction and human colorectal cancer recurrence. Cancer Res. 2009;69(6):2685–2693. - PubMed

LinkOut - more resources